BERNARDS RENE purchased 10K shares of LIXTE BIOTECHNOLOGY HOLDINGS, INC. on the open market
Open‑market purchase worth $24.1K. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 10/4/2023ACC: 0001493152-23-035712
Director
Since Jun 2022
+10K
Net shares
Net buyer
$24.1K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
10K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.47K
Price / share
$2.29
Trade value
$10.24K
% of position
New position
10/2/2023
-4.47K→N/A
Common Stock
Direct
Shares
+5.53K
Price / share
$2.51
Trade value
$13.87K
% of position
New position
10/3/2023
-5.53K→N/A
Total
Net shares
+10K
Net value
$24.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/2/2023 | P · Purchase | +4.47K | $2.29 | $10.24K | New position | -4.47K | N/A |
| Common Stock Direct | 10/3/2023 | P · Purchase | +5.53K | $2.51 | $13.87K | New position | -5.53K | N/A |
| Total | +10K | $24.12K | ||||||
Derivative Transactions0
No derivative transactions reported